EQS-Adhoc

    117 Aufrufe 117 0 Kommentare 0 Kommentare

    aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments

    Für Sie zusammengefasst
    • Auditor to terminate audit, no opinion issued.
    • Audit impediments due to missing financial documents.
    • Publication of statements to avoid hefty penalties.

    EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report
    aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments

    22-Aug-2024 / 18:05 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    aap Implantate AG ("Company") today received notification from the auditor, Baker Tilly GmbH & Co KG Wirtschaftsprüfungsgesellschaft ("Auditor"), that it will conclude the audit of the annual and consolidated financial statements on Friday, August 23, 2024, and will declare that it will not issue an audit opinion due to audit impediments. The auditor justifies this by stating that it is not in a position to complete the audit because, in its view, the necessary documents relating to the HGB individual financial statements have not been submitted in full.

    The publication of the 2023 annual financial statements despite the fact that the audit has not been completed is therefore accompanied by a note of refusal. The decision to publish was made due to the threat of a six-figure penalty payment. The Executive Board is working with all available resources to resolve the audit impediment and eliminate it for the 2024 annual and consolidated financial statements.

    aap Implants AG

    Management Board

     

     

     

     





    Contact:
    aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin
    Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de

    End of Inside Information

    22-Aug-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com

    Language: English
    Company: aap Implantate AG
    Lorenzweg 5
    12099 Berlin
    Germany
    Phone: +49 (0) 30 75 019-0
    Fax: +49 (0) 30 75 019-111
    E-mail: info@aap.de
    Internet: www.aap.de
    ISIN: DE000A3H2101
    WKN: A3H210
    Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1973467

     
    End of Announcement EQS News Service

    1973467  22-Aug-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1973467&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-Adhoc aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments 22-Aug-2024 / 18:05 CET/CEST Disclosure of an inside information acc. to …